DHEA (n = 15) | Placebo (n = 15) | p | |
---|---|---|---|
*The p values for continuous variables were obtained with one way analysis of variance, and p values for categorical variables from a χ2 test. | |||
Age (years) | |||
Mean/median (SD) | 33.3/32.0 (10.2) | 32.0/32.0 (9.6) | 0.672 |
Range | 18.0 to 62.0 | 18.0 to 59.0 | |
Prednisone dose (mg/day) | |||
Mean/median (SD) | 7.0/7.5 (3.1) | 6.7/5.0 (3.1) | 0.732 |
Range | 0.0 to 10.0 | 0.0 to 10.0 | |
Pre-menopausal | 14 (93.3%) | 14 (93.3%) | 1.000 |
Cytotoxic use at baseline | 6 (40.0%) | 6 (40.7%) | 0.940 |
Prednisone use at baseline | 14 (93.3%) | 14 (93.3%) | 1.000 |
Antimalarial use at baseline | 9 (65.0%) | 10 (66.6%) | 0.602 |